Response Pharmaceuticals is a biotechnology and pharmaceutical company.
Response Pharmaceuticals has raised $3.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
Response Pharmaceuticals's investors include CrossWork.us, STONEHAVEN, LLC, Collage Partners, Flying Cloud Securities.
Response Pharmaceuticals is headquartered in Mclean, United States.
Response Pharmaceuticals is a biotechnology and pharmaceutical company.
Response Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Response Pharmaceuticals — Funding & Investors." VCBacked, June 28, 2024, https://www.vcbacked.co/company/response-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2024). Response Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/response-pharmaceuticals
{{cite web |title=Response Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/response-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated